11 – 20 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
(
- Contribution to journal › Article
-
Mark
Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.
(
- Contribution to journal › Article
-
Mark
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
(
- Contribution to journal › Article
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
- 2014
-
Mark
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
(
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article